These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25228365)

  • 41. Association of epidermal growth factor receptor activating mutations with low ERCC1 gene expression in non-small cell lung cancer.
    Gandara DR; Grimminger P; Mack PC; Lara PN; Li T; Danenberg PV; Danenberg KD
    J Thorac Oncol; 2010 Dec; 5(12):1933-8. PubMed ID: 20975603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer.
    Park S; Holmes-Tisch AJ; Cho EY; Shim YM; Kim J; Kim HS; Lee J; Park YH; Ahn JS; Park K; Jänne PA; Ahn MJ
    J Thorac Oncol; 2009 Jul; 4(7):809-15. PubMed ID: 19487967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop.
    Pirker R; Herth FJ; Kerr KM; Filipits M; Taron M; Gandara D; Hirsch FR; Grunenwald D; Popper H; Smit E; Dietel M; Marchetti A; Manegold C; Schirmacher P; Thomas M; Rosell R; Cappuzzo F; Stahel R;
    J Thorac Oncol; 2010 Oct; 5(10):1706-13. PubMed ID: 20871269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NSCLC Patients Harbouring Rare or Complex EGFR Mutations Are More Often Smokers and Might Not Benefit from First-Line Tyrosine Kinase Inhibitor Therapy.
    Kauffmann-Guerrero D; Huber RM; Reu S; Tufman A; Mertsch P; Syunyaeva Z; Jung A; Kahnert K
    Respiration; 2018; 95(3):169-176. PubMed ID: 29190621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EGFR mutations in non-small cell lung cancer: an audit from West China Hospital.
    Tang Y; Wang WY; Zheng K; Jiang L; Zou Y; Su XY; Chen J; Zhang WY; Liu WP
    Expert Rev Mol Diagn; 2016 Aug; 16(8):915-9. PubMed ID: 27348572
    [TBL] [Abstract][Full Text] [Related]  

  • 46. S768I Mutation in EGFR in Patients with Lung Cancer.
    Leventakos K; Kipp BR; Rumilla KM; Winters JL; Yi ES; Mansfield AS
    J Thorac Oncol; 2016 Oct; 11(10):1798-801. PubMed ID: 27211795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Clinical Significance of the Insulin-Like Growth Factor-1 Receptor Polymorphism in Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation.
    Liu TC; Hsieh MJ; Liu MC; Chiang WL; Tsao TC; Yang SF
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213344
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CHFR hypermethylation and EGFR mutation are mutually exclusive and exhibit contrastive clinical backgrounds and outcomes in non-small cell lung cancer.
    Koga T; Takeshita M; Yano T; Maehara Y; Sueishi K
    Int J Cancer; 2011 Mar; 128(5):1009-17. PubMed ID: 20473935
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned.
    Lee DH; Srimuninnimit V; Cheng R; Wang X; Orlando M
    Cancer Res Treat; 2015 Oct; 47(4):549-54. PubMed ID: 25943319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The expression of programmed death receptor 1 in non-small cell lung cancer and its clinicopathological features and prognosis showed a connection with epidermal growth factor receptor gene mutations].
    Yin H; Liao CG; Wang YQ; Li Z; Fan LL; Qian ML; Lu N
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):419-423. PubMed ID: 28635230
    [No Abstract]   [Full Text] [Related]  

  • 51. EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey.
    Yatabe Y; Kerr KM; Utomo A; Rajadurai P; Tran VK; Du X; Chou TY; Enriquez ML; Lee GK; Iqbal J; Shuangshoti S; Chung JH; Hagiwara K; Liang Z; Normanno N; Park K; Toyooka S; Tsai CM; Waring P; Zhang L; McCormack R; Ratcliffe M; Itoh Y; Sugeno M; Mok T
    J Thorac Oncol; 2015 Mar; 10(3):438-45. PubMed ID: 25376513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases.
    Ge M; Zhuang Y; Zhou X; Huang R; Liang X; Zhan Q
    J Neurooncol; 2017 Nov; 135(2):413-418. PubMed ID: 28780743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer in the Real-World Setting in Central Europe: The INSIGHT Study.
    Ramlau R; Cufer T; Berzinec P; Dziadziuszko R; Olszewski W; Popper H; Bajcic P; Dusšk L; Zbozinkova Z; Pirker R;
    J Thorac Oncol; 2015 Sep; 10(9):1370-1374. PubMed ID: 26291014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical Impact of Rare and Compound Mutations of Epidermal Growth Factor Receptor in Patients With Non-Small-Cell Lung Cancer.
    Martin J; Lehmann A; Klauschen F; Hummel M; Lenze D; Grohé C; Tessmer A; Gottschalk J; Schmidt B; Pau HW; Witt C; Moegling S; Kromminga R; Jöhrens K
    Clin Lung Cancer; 2019 Sep; 20(5):350-362.e4. PubMed ID: 31175009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidermal growth factor receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with advanced non-small cell lung cancer in Switzerland: A comprehensive evaluation of real world practices.
    Ess SM; Herrmann C; Frick H; Krapf M; Cerny T; Jochum W; Früh M
    Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28557060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EGFR mutation testing in non-small cell lung cancer (NSCLC).
    Al Dayel F
    J Infect Public Health; 2012 Dec; 5 Suppl 1():S31-4. PubMed ID: 23244184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiological Characteristics,
    Syrigos KN; Georgoulias V; Zarogoulidis K; Makrantonakis P; Charpidou A; Christodoulou C
    Anticancer Res; 2018 Jun; 38(6):3735-3744. PubMed ID: 29848736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genotyping of EGFR Mutations from Bronchial Cytological Specimens in Slovakian Lung Cancer Patients.
    Baluchova K; Zahradnikova M; Bakes P; Trubacova S; Novosadova H; Halasova E; Majer I; Hlavcak P
    Adv Exp Med Biol; 2016; 934():49-61. PubMed ID: 27235166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study.
    Han B; Tjulandin S; Hagiwara K; Normanno N; Wulandari L; Laktionov K; Hudoyo A; He Y; Zhang YP; Wang MZ; Liu CY; Ratcliffe M; McCormack R; Reck M
    Lung Cancer; 2017 Nov; 113():37-44. PubMed ID: 29110846
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Immunohistochemical detections of EGFR status in NSCLC].
    Wang J; Liu C; Zhong D; Xu D; Ning C; Ma Q
    Zhongguo Fei Ai Za Zhi; 2015 Apr; 18(4):212-8. PubMed ID: 25936885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.